ZiP Diagnostics Pty Ltd (ZiP Diagnostics) is a biotech company that develops solutions for the diagnosis of infectious diseases. It offers ZiP-CoVx assay to detect viral RNA for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); ZiP-CoVx-T1 and ZiP-CoVx-C2 test systems that incorporate ZiP-CoVx assay to diagnose coronavirus. The company is also designing ZiP CT-NG, a molecular diagnostic test system targeting chlamydia and gonorrhea. Zip Diagnostics utilizes point-of-care (PoC) systems that contain a proprietary format isothermal molecular diagnostic technology to identify human infectious diseases, viral hepatitis, respiratory viruses, vector-borne diseases and tuberculosis. The company has laboratory and production facilities in Victoria, Australia. Zip Diagnostics is headquartered in Collingwood, Victoria, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ZiP Diagnostics Pty Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- ZiP Diagnostics Pty Ltd Company Overview
- ZiP Diagnostics Pty Ltd Company Snapshot
- ZiP Diagnostics Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview
- ZiP Diagnostics Pty Ltd - Pipeline Analysis Overview
- ZiP Diagnostics Pty Ltd - Key Facts
- ZiP Diagnostics Pty Ltd - Major Products and Services
- ZiP Diagnostics Pty Ltd Pipeline Products by Development Stage
- ZiP Diagnostics Pty Ltd Ongoing Clinical Trials by Trial Status
- ZiP Diagnostics Pty Ltd Pipeline Products Overview
- Point-of-Care Diagnostic Test - Influenza
- Point-of-Care Diagnostic Test - Influenza Product Overview
- Point-of-Care Diagnostic Test - Malaria
- Point-of-Care Diagnostic Test - Malaria Product Overview
- Point-of-Care Diagnostic Test - Tuberculosis
- Point-of-Care Diagnostic Test - Tuberculosis Product Overview
- ZiP-ARRAY Test System
- ZiP-ARRAY Test System Product Overview
- ZiP-BBV-H4
- ZiP-BBV-H4 Product Overview
- ZiP-CoVx-P2
- ZiP-CoVx-P2 Product Overview
- ZiP-CoVx-P2 Clinical Trial
- Zip-H4 System - CT-NG Point-Of-Care Test
- Zip-H4 System - CT-NG Point-Of-Care Test Product Overview
- ZiP-H4 Test System
- ZiP-H4 Test System Product Overview
- ZiP-P2 Test System
- ZiP-P2 Test System Product Overview
- ZiP Diagnostics Pty Ltd - Key Competitors
- ZiP Diagnostics Pty Ltd - Key Employees
- ZiP Diagnostics Pty Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- ZiP Diagnostics Pty Ltd, Recent Developments
- Apr 30, 2021: ZiP Awarded $750k Commercialisation Grant
- Oct 31, 2020: ZiP has secured a prestigious grant from the British Society of Antimicrobial Chemotherapy (BSAC) to assess its new COVID point-of-care test in Ghana
- Jul 20, 2020: Australian medtech research efforts boosted by $18.8 million
- Jul 19, 2020: ZiP Diagnostics secures $600,000 federal grant for COVID-19 test
- Jun 30, 2020: ZiP starts pre-clinical testing of SARS-CoV-2 test system
- Oct 31, 2019: ZiP Diagnostics announces $1m contract
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- ZiP Diagnostics Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview
- ZiP Diagnostics Pty Ltd Pipeline Products by Equipment Type
- ZiP Diagnostics Pty Ltd Pipeline Products by Indication
- ZiP Diagnostics Pty Ltd Ongoing Clinical Trials by Trial Status
- ZiP Diagnostics Pty Ltd, Key Facts
- ZiP Diagnostics Pty Ltd, Major Products and Services
- ZiP Diagnostics Pty Ltd Number of Pipeline Products by Development Stage
- ZiP Diagnostics Pty Ltd Pipeline Products Summary by Development Stage
- ZiP Diagnostics Pty Ltd Ongoing Clinical Trials by Trial Status
- ZiP Diagnostics Pty Ltd Ongoing Clinical Trials Summary
- Point-of-Care Diagnostic Test - Influenza - Product Status
- Point-of-Care Diagnostic Test - Influenza - Product Description
- Point-of-Care Diagnostic Test - Malaria - Product Status
- Point-of-Care Diagnostic Test - Malaria - Product Description
- Point-of-Care Diagnostic Test - Tuberculosis - Product Status
- Point-of-Care Diagnostic Test - Tuberculosis - Product Description
- ZiP-ARRAY Test System - Product Status
- ZiP-ARRAY Test System - Product Description
- ZiP-BBV-H4 - Product Status
- ZiP-BBV-H4 - Product Description
- ZiP-CoVx-P2 - Product Status
- ZiP-CoVx-P2 - Product Description
- ZiP-CoVx-P2 - Clinical Validation of ZiP-CoVx-P2 for COVID-19 point-of-care test in children and adults in Ghana (VaZico Study Ghana).
- ZiP-CoVx-P2 - Optimisation and Clinical Validation of a New Point-Of-Care Diagnostic Test (Zip-Covx-P2) For COVID-19 Among Sars-Cov-2-Positive Adults Within the Alfred Hospital Care Pathway (Coop Study)
- Zip-H4 System - CT-NG Point-Of-Care Test - Product Status
- Zip-H4 System - CT-NG Point-Of-Care Test - Product Description
- ZiP-H4 Test System - Product Status
- ZiP-H4 Test System - Product Description
- ZiP-P2 Test System - Product Status
- ZiP-P2 Test System - Product Description
- ZiP Diagnostics Pty Ltd, Key Employees
- ZiP Diagnostics Pty Ltd, Other Locations
- Glossary
- ZiP Diagnostics Pty Ltd Pipeline Products by Equipment Type
- ZiP Diagnostics Pty Ltd Pipeline Products by Development Stage
- ZiP Diagnostics Pty Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AusDiagnostics Pty Ltd
- Ellume Ltd
- Alere Holdings Pty Limited
